Analysts Set Transcat, Inc. (NASDAQ:TRNS) Target Price at $114.00

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $112.20.

A number of equities research analysts recently commented on the stock. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Lake Street Capital assumed coverage on shares of Transcat in a report on Thursday. They issued a "buy" rating and a $105.00 price target on the stock. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $116.00 price target on shares of Transcat in a report on Wednesday, June 25th.

Institutional Investors Weigh In On Transcat

A number of hedge funds and other institutional investors have recently bought and sold shares of TRNS. Jones Financial Companies Lllp grew its position in Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after acquiring an additional 309 shares in the last quarter. Quantbot Technologies LP purchased a new position in Transcat in the first quarter worth $76,000. State of Wyoming purchased a new position in Transcat in the first quarter worth $95,000. Aquatic Capital Management LLC grew its position in Transcat by 1,052.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,052 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in Transcat by 10,137.5% in the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,622 shares in the last quarter. Institutional investors own 98.34% of the company's stock.

Transcat Stock Performance

Shares of NASDAQ TRNS traded down $0.80 during midday trading on Thursday, reaching $86.59. The company's stock had a trading volume of 76,227 shares, compared to its average volume of 91,657. Transcat has a 12-month low of $67.56 and a 12-month high of $147.12. The firm has a 50 day moving average price of $83.67 and a 200-day moving average price of $84.30. The stock has a market capitalization of $806.85 million, a P/E ratio of 55.51 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.29 and a quick ratio of 1.87.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). The business had revenue of $77.13 million during the quarter, compared to analysts' expectations of $76.40 million. Transcat had a return on equity of 6.47% and a net margin of 5.21%. The business's revenue was up 8.8% on a year-over-year basis. As a group, equities analysts predict that Transcat will post 2.3 earnings per share for the current year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.